Full Press Release Details
argenx Appoints Steve Krognes to Board of Directors.
ARGX
argenx Appoints Steve Krognes to Board of Directors
Key Takeaway: argenx Appoints Steve Krognes to Board of Directors
Price reaction · baseline $366.53 (2023-02-24 close) · 2 other ARGX headline(s) in the window, move may be shared
day 0 close · peak
+1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+36%
120-day peak, hindsight
Typical move
4.7%
average across 12 past catalysts
Lead asset
Empasiprubart
Phase 2 · AChR-Ab Seropositive Generalized Myasthenia Gravis